Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



SEVERINO MICHAEL Create: Alert

All | News | Filings
Date FiledTypeDescription
05/15/2023 4 SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.
Txns: Granted 9,808 shares @ $0
05/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2022 4 SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.
Txns: Granted 6,693 shares @ $0
05/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.
Txns: Granted 1,215 shares @ $0
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2021 4 SEVERINO MICHAEL (Vice Chairman) has filed a Form 4 on AbbVie Inc.
Txns: Gifted 583 shares @ $0
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/06/2020 4 SEVERINO MICHAEL (Vice Chairman) has filed a Form 4 on AbbVie Inc.
Txns: Sold 90,679 shares @ $93.61, valued at $8.5M
04/24/2020 4 SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.
Txns: Granted 10,022 shares @ $0
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2019 4 SEVERINO MICHAEL (Vice Chairman) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 26,710 shares @ $79.41, valued at $2.1M
02/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2018 4 SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.
Txns: Sold 20,800 shares @ $96.9688, valued at $2M
Sold 29,200 shares @ $97.9147, valued at $2.9M
03/02/2018 4 SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 27,683 shares @ $118.26, valued at $3.3M
Sold 2,643 shares @ $117.928, valued at $311.7k
02/16/2018 4 SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.
Txns: Granted 15,375 shares @ $0
Granted 17,319 shares @ $0
Granted 14,991 shares @ $0
Granted 46,320 options to buy @ $114.36, valued at $5.3M
11/13/2017 4 SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.
Txns: Sold 25,633 shares @ $94.6909, valued at $2.4M
06/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/03/2016 4 SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 21,574 shares @ $62.83, valued at $1.4M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy